HkeyBiospecializesinpreclinicalstudiesfordrugdiscovery.Exploreourcutting-edgeresearchinautoimmunediseasesandinnovativeanimalmodels.

Synaptic’smissionistocreateaplatformthatinspiresandsupportsteammemberstogrowwhileimprovingarrhythmiaandrelateddiseaseoutcomesina

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.

AboutUs Life-saving,life-changingandlife-enhancing 挽救生命改变命运HearttoHeartisaspecialfundofRenDeFoundation. WeareShanghaibased,butprovidecorrectivesurgeryforChinesechildrenfromalloverChinawithcongenitalheartdisease(CHD)whoseparentsareunabletoaffordthesurgery. TodateH2Hhassponsoredover3,659

智云健康是一站式慢病管理与智慧医疗平台,数字健康领导者.旗下包括:医院慢病管理SaaS系统-智云医汇;链接慢病患者与医生的互联网医院;药店智能处方SaaS系统-智云问诊.Cloudrisone-stopchronicdiseasemanagementandsmartmedicalplatform,digitalhealthleader.Cloudr

IslocationinTaizhoushoreoftheEastChinaSeaBridgeStreet,TAIZHOUYUANHUAMICROSPRAYERCO.,LTD,foundedin1990,isthehead,Chinabeforethelargercompressionsprayermanufacturers.Mainproductsincludehandtriggersprayer,hand-pressingtypeSprayers,liquiddistrbutor.Widelyusedinhealthanddiseaseprevention,disinfectionPHILOSOPHY,flowersfountain,lroningspray,Poultrymosquito,cleaningfurnitureorwindows,chemicalandpharmaceuticalpackaging,

爱达健康是一个由医生，科学家和行业先锋组成的团队共同创立的全球化的医疗健康公司。爱达通过人工智能技术与现有医学知识的融合，致力于创造个性化医疗和健康管理的全新可能性。

Nationalhigh-techbiotechnologyenterpriseintegratingR&D,production,thefounderteamofthecompanycomesfromfamousuniversitiesathomeandabroad.

BiomedicalandEnvironmentalSciences(BES)isapeer-reviewedcomprehensivemedicaljournalsponsoredbytheChineseCenterforDiseaseControlandPrevention.

TheBaseTherapeuticsfoundingteamisacombinationofthetopscientistsandindustryleaders.Theco-foundersincludethemostcitedscientistsinbaseeditingandprimeeditingfieldintheworld,leadingNKscientistsintheindustry,topcellthera

Zeta-Life,Isaprofessionalengagedinlifescienceinstrumentsandreagentsagentsalesandservices,oneofthewell-knownenterprises.Ouragentathomeandabroadwell-knownbiotechnologyproducts,salesoftheinstruments,consumables,molecularandbiochemicalreagent,immunologicalreagentsandcellculturereagents,hasbeenwidelyusedinlifescienceresearch,developmentandapplication,pharmacy,diseasediagnosisandcontrol,populationandhealth,biologytechnologyfields.CustomersthroughouttheUniversity,ResearchInstitute,hospitals,healthandepidemicprevention,commodityinspectionandquarantine,pharmaceuticalcompanies,BiotechCorpandfoodindustryandotherunits.

健康160挂号网疾病频道为你介绍各种疾病的疾病预防、疾病保健、疾病治疗、疾病用药、疾病诊断等内容,包括儿童疾病、妇产科疾病、慢性病、肿瘤疾病、五官科疾病、中医科疾病等

BeijingDCNOrthopaedicHospital,theauthorityofBeijingOrthopaedicHospital,hasateamofseniororthopaedicexpertsandanorthopaedicrehabilitationcenterwithadvancedequipment.ItisaprivateorthopaedichospitaldesignatedbytheathletesofthenationalteamoftheChineseOlympicCommittee.Itspecializesinglutealmusclecontracture,gout,femoralheadnecrosis,lumbardischerniation,cervicalspondylosis,lowerlimborthopedics,etc.Orthopedichospitalhotline:010-52713366

HarbourBioMed(HBMHoldings)isaglobalbiopharmaceuticalcompanycommittedtother&dandcommercializationofnovelantibodytherapeuticsinoncologyandimmunologicaldiseases.